M
yeloid sarcoma, also known as granulocytic sarcoma, extramedullary myeloid leukemia, or chloroma, is the soft tissue equivalent of acute myeloid leukemia. It is found in less than 1% of patients with acute myeloid leukemia (1) , but can also be found as a precursor lesion in patients who have not been diagnosed with acute myeloid leukemia. In up to 47% of patients, myeloid sarcoma is initially misdiagnosed as malignant lymphoma (2) . It is important to properly diagnose this entity because it should be treated as acute myeloid leukemia. We present the case of an 84-year-old man with no prior history of malignancies presenting with airway obstruction, initially believed to be caused by non-Hodgkin lymphoma, that was treated unsuccessfully with steroids while the biopsy was being evaluated. Th e biopsy of the lesion was diagnosed as a myeloid sarcoma.
CASE REPORT
An 84-year-old man with previous end-stage renal disease, type 2 diabetes mellitus, hypertension, and coronary artery disease presented with dyspnea that had progressively worsened over a 3-week period. Th e dyspnea was present at rest and worsened in the supine position. He had a mild cough with minimal sputum production. Additionally, the patient had recently noticed that his appetite had decreased and he had been losing weight. He did not have fever or night sweats.
A chest computed tomography scan showed a superior mediastinal mass measuring up to 7.3 cm in greatest dimension. It entirely encased the trachea and narrowed the lumen to 4 mm at one point ( Figure 1) . Th e mass also compressed the right brachiocephalic vein and the upper third of the esophagus. Th e patient's white blood cell count was 2.2 K/μL; hemoglobin, 10.4 g/dL; hematocrit, 33.3%; and platelets, 81 K/μL.
A biopsy of the mediastinal mass disclosed large atypical discohesive cells percolating through a background of sclerotic tissue. Most cells had prominent nucleoli, and a few cells had small indistinct granules. On initial morphologic assessment, the mass was most likely a lymphocytic neoplasm, and a diff use large cell lymphoma was considered. A battery of immunostains (CD3, CD20, CD10, BCL-1, BCL-2, BCL-6, Mum-1, cMyc, Ki-67, EBER, CD34, CD79a, CD4, and CD30) was performed, but of these stains only BCL-2 (90%), CD34 (100%), and Ki-67 (40%-45%) were positive. Additional stains (pancytokeratin, TdT, myeloperoxidase, CD15, CD68, and CD33) were performed to involvement to airway obstruction from a mediastinal mass (6, 7) . Due to the broad range of symptoms that can be caused by primary myeloid sarcoma, a high index of suspicion is necessary to avoid missing or delaying this diagnosis.
Th ese lesions often are initially diagnosed or worked up and treated as a lymphoma. In our case, the patient initially was treated with high-dose steroids for presumed lymphoma while the tissue was being examined by pathology. Th e fi rst suspicion that this might be a myeloid sarcoma came when the initial round of immunohistochemical stains, which were designed to identify a high-grade lymphoma, failed to establish that diagnosis. On the day of marrow biopsy, the clinical team visited pathology to discuss the failure of the patient to respond to high-dose steroids. Further immunohistochemical stains for myeloid sarcoma were ordered and the correct diagnosis was established. It is important to distinguish between a large-cell lymphoma and a myeloid sarcoma for treatment purposes.
Acute myeloid sarcomas are generally treated in the same manner as acute myeloid leukemia. Overall prognosis is extremely poor, with a median survival of 9.5 months; this includes both primary and secondary myeloid sarcomas (8) . One older series of 90 patients with primary myeloid sarcoma showed a median survival of 22 months (9) . Due to the numerous locations in which myeloid sarcoma can present, it is likely that the prognosis is largely dependent on the location and symptoms.
elucidate the origin of the tumor cells, and myeloperoxidase, TdT, CD15, and CD33 were positive (Figure 2 ). With this immunostaining profi le, the tumor was diagnosed as a myeloid sarcoma.
Th e patient then had a bone marrow biopsy that showed 25% cellularity with trilineage hematopoiesis and only 1% myeloblasts by morphology, 1% to 2% by CD34 immunohistochemistry, and no evidence of a high-grade hematopoietic neoplasm by fl ow cytometry. Mild megakaryocytic dyspoiesis was identifi ed. A myelodysplastic syndrome fl uorescence in situ hybridization study on the patient's bone marrow came back positive for deletions of chromosomes 5q and 20q in 74% and 22% of the cells examined, respectively, which is suffi cient in the context of refractory cytopenia for a presumptive diagnosis of myelodysplastic syndrome, even in the absence of overt morphologic evidence.
Th e patient remained intubated without any clinical improvement following high-dose corticosteroid therapy. Due to the patient's multiple comorbidities and age, chemotherapy was considered to be detrimental to the patient. By request of the family, he was transferred to the local Veteran's Administration hospital, intubated, and sedated without plans for further treatment.
DISCUSSION
Th is patient developed a myeloid sarcoma likely arising in a lymph node or the soft tissue of the mediastinum leading to immediately life-threatening airway obstruction. Myeloid sarcoma is an extremely aggressive extramedullary manifestation of acute myeloid leukemia. Primary myeloid sarcoma, defi ned as myeloid sarcoma without evidence of acute myeloid leukemia in the bone marrow, is rare (3). It is generally considered a precursor lesion for acute myeloid leukemia; one series prior to the advent of eff ective chemotherapy showed 29 of 30 cases progressing to overt acute myeloid leukemia in a median time of 7 months (4). Granulocytic sarcomas have been described in myelodysplastic and myeloproliferative disorders (5) .
Previous case reports of myeloid sarcomas described compression-related symptoms as the initial presentation. Th e symptoms can vary dramatically based on the site of presentation, ranging from back pain and bilateral leg weakness from spinal cord compression to intestinal obstruction and appendicitis from mesenteric a b 
